近期，猪价低迷与生猪产能调控是行业谈论较多的热点。 11月4日—7日，新希望（000876.SZ，股价10.05元，市值452.51亿元）接连召开多场策略会，对近期养猪市场的相关信息进行了回应。 《每日经济新闻》记者（以下简称"每经记者"）梳理发现，新希望今年前三季度养猪亏损，主要亏损期间在第三季度，而第三季度同样是国内猪价低点。新 希望坦言，近期11元/公斤左右的猪价已使行业陷入全面亏损，很多头部企业的大部分场线也处于亏损状态。此外，新希望将在明年1月底之前逐步调减能繁 母猪存栏规模，明年的出栏量也会有一定程度调减。 "11元/公斤猪价已使全行业亏损" 在连场策略会上，新希望董秘赵亮等出席，重点谈及目前的饲料市场和养猪市场。 从前三季度业绩来看，新希望累计实现归母净利润7.6亿元，同比增长近400%。其中，第三季度实现归母净利润513万元。 新希望的业绩收入主要来自饲料。前三季度，饲料方面累计实现归母净利10.3亿元，同比增长23%，继续保持月均1亿元以上的盈利水平。其中，第三季度 实现归母净利润4.3亿元，月均盈利达到1.4 亿元。 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初 ...

Wave Life Sciences (NasdaqGM:WVE) FY Conference November 11, 2025 10:00 AM ET Speaker1Good morning, and thank you for joining Guggenheim's 2025 Healthcare Innovations Conference. I am Deb Jit, one of the therapeutic analysts, and my privilege to welcome our next presenting company, Wave Life Sciences. From Wave, I have Paul Bolno, the President and CEO. Thank you so much for making time for us, Paul.Speaker0Thank you for having us.Speaker1Do you want to give a quick 30-second lay of the land for people who ...

Gossamer Bio (NasdaqGS:GOSS) FY Conference November 11, 2025 10:00 AM ET Speaker2All right. I think we're ready to get started here. Thanks so much for joining us again for our second annual Guggenheim Healthcare Innovation Conference and on day two. Next up in this room, I'm Bob Mulvaney, one of the bio pharma analysts here at Daniel Crozier from the Guggenheim team, up on the stage with me as well. Next in this room, we have the Gossamer team. We have Brian Geraghty, the COO and CFO, and Bob Smith, the CE ...

Investor Presentation November 2025 LGTMs: Date: Peter K. LGTM 11.10.25 Legal (Karen / Peter R.) LGTM Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding Adjusted EBITDA, Adjusted Net income from continuing operations, Adjusted SG&A, Adjusted SG&A as a percentage of revenue, Insurance BER, N ...

Summit Midstream (NYSE:SMC) Q3 2025 Earnings Call November 11, 2025 10:00 AM ET Speaker3Good day, and thank you for standing by. Welcome to the third quarter of 2025 Summit Midstream Corporation earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is rais ...

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK) announced today that the real estate services firm ranked sixth in the Top Ten 2026 Military Friendly® Employers with revenue over $5 billion for its meaningful efforts to recruit, retain and develop veteran talent in the U.S. The firm has now been recognized as a Top Ten Military Friendly® Employer for four consecutive years, and a Military Friendly® Employer for eight consecutive years. "Veterans exemplify the discipline, leadersh. ...

SFL (NYSE:SFL) Q3 2025 Earnings Call November 11, 2025 10:00 AM ET Speaker0Welcome to SFL's Third Quarter 2025 Conference Call. My name is Espen Olesen, and I'm Vice President of Investor Relations in SFL. Our CEO, Ole Hjertaker, will start the call with an overview of the third quarter highlights. Then, our Chief Operating Officer, Trym Sjølie, will comment on vessel performance matters, followed by our CFO, Aksel Olesen, who will take us through the financials. The conference call will be concluded by ope ...

Celldex Therapeutics (NasdaqCM:CLDX) FY Conference November 11, 2025 10:00 AM ET Speaker0All right. Good morning, everyone. Welcome to Guggenheim Healthcare Innovation Conference. Our next presenting company is Celldex Therapeutics. We have a few executives from the company here in our room. We will be chatting here with Tibor Keler, who is the Chief Scientific Officer. We have Diane Young, who is the Chief Medical Officer. We have Sarah Cavanaugh. She's the SVP Corporate Affairs. I have prepared a list of ...

Repligen (NasdaqGS:RGEN) 2025 Conference November 11, 2025 10:00 AM ET Speaker1Quarter.I've been wrapping up the quarter for a lot of these sessions as a kickoff for Repligen. It was a good quarter. It was 18% organic growth. Each of the key product areas was up double digits. Op margins were 14.2% down 70 basis points. You beat the street by $0.05 on the bottom line. Maybe just talk a little bit about what got you there and what you think about where the various components of the business are right now.Yea ...

OSHKOSH, Wis.--(BUSINESS WIRE)---- $OSK #oshkoshcorporation--Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose-built vehicles, equipment and services, today announced that it has earned the 2026 Military Friendly® Employer designation. This marks the 15th consecutive year that Oshkosh Corporation has been recognized for its commitment to creating meaningful career opportunities for veterans and their spouses, helping to enrich their lives and support their futures. "At Oshkosh, putting people ...